ReviewFrontiers in oncology2022

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders.

Argiris Symeonidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.